These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 21807979
1. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A. Antimicrob Agents Chemother; 2011 Oct; 55(10):4821-7. PubMed ID: 21807979 [Abstract] [Full Text] [Related]
4. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS. Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632 [Abstract] [Full Text] [Related]
5. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA, Mickail N, Eisenstein L. Heart Lung; 2007 Sep; 36(6):456-61. PubMed ID: 18005808 [Abstract] [Full Text] [Related]
7. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. DeRyke CA, Sutherland C, Zhang B, Nicolau DP, Kuti JL. Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618 [Abstract] [Full Text] [Related]
12. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Vouillamoz J, Moreillon P, Giddey M, Entenza JM. J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515 [Abstract] [Full Text] [Related]
13. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis. Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B. Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476 [Abstract] [Full Text] [Related]
14. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Furustrand Tafin U, Corvec S, Betrisey B, Zimmerli W, Trampuz A. Antimicrob Agents Chemother; 2012 Apr; 56(4):1885-91. PubMed ID: 22252806 [Abstract] [Full Text] [Related]
15. Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model. Ozcimen M, Kurtoglu MG, Goktas S, Omeroglu E, Sakarya Y, Alpfidan I, Ozcımen S, Sakarya R, Yener HI, Demir LS, Saglam F. Curr Eye Res; 2016 Apr; 41(2):232-9. PubMed ID: 25658242 [Abstract] [Full Text] [Related]
18. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
19. Emergence of High-level Gentamicin Resistance among Enterococci Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working. Labibzadeh M, Kaydani GA, Savari M, Ekrami A. Pol J Microbiol; 2018 Aug; 67(4):401-406. PubMed ID: 30550226 [Abstract] [Full Text] [Related]
20. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Tsuji BT, Rybak MJ. Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344 [Abstract] [Full Text] [Related] Page: [Next] [New Search]